Smoking Status, Nicotine Medication, Vaccination, and COVID-19 Hospital Outcomes: Findings from the COVID EHR Cohort at the University of Wisconsin (CEC-UW) Study
Nicotine and Tobacco Research · 2023
DOI: 10.1093/ntr/ntac201 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nicotine and Tobacco Research, 2023. Verfasst von Thomas M Piasecki und 49 weiteren Autor:innen. Beteiligte Einrichtung: Center for Tobacco Research and Intervention, School of Medicine and Public Health, University of Wisconsin-Madison, Madison, WI, USA. Hauptthemen laut MEDLINE: Smoking Cessation, COVID-19. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NCI NIH HHS, NCATS NIH HHS, National Cancer Institute.
Abstract (Originalsprache)
Introduction
Available evidence is mixed concerning associations between smoking status and COVID-19 clinical outcomes. Effects of nicotine replacement therapy (NRT) and vaccination status on COVID-19 outcomes in smokers are unknown.
Methods
Electronic health record data from 104 590 COVID-19 patients hospitalized February 1, 2020 to September 30, 2021 in 21 U.S. health systems were analyzed to assess associations of smoking status, in-hospital NRT prescription, and vaccination status with in-hospital death and ICU admission.
Results
Current (n = 7764) and never smokers (n = 57 454) did not differ on outcomes after adjustment for age, sex, race, ethnicity, insurance, body mass index, and comorbidities. Former (vs never) smokers (n = 33 101) had higher adjusted odds of death (aOR, 1.11; 95% CI, 1.06–1.17) and ICU admission (aOR, 1.07; 95% CI, 1.04–1.11). Among current smokers, NRT prescription was associated with reduced mortality (aOR, 0.64; 95% CI, 0.50–0.82). Vaccination effects were significantly moderated by smoking status; vaccination was more strongly associated with reduced mortality among current (aOR, 0.29; 95% CI, 0.16–0.66) and former smokers (aOR, 0.47; 95% CI, 0.39–0.57) than for never smokers (aOR, 0.67; 95% CI, 0.57, 0.79). Vaccination was associated with reduced ICU admission more strongly among former (aOR, 0.74; 95% CI, 0.66–0.83) than never smokers (aOR, 0.87; 95% CI, 0.79–0.97).
Conclusions
Former but not current smokers hospitalized with COVID-19 are at higher risk for severe outcomes. SARS-CoV-2 vaccination is associated with better hospital outcomes in COVID-19 patients, especially current and former smokers. NRT during COVID-19 hospitalization may reduce mortality for current smokers.
Implications
Prior findings regarding associations between smoking and severe COVID-19 disease outcomes have been inconsistent. This large cohort study suggests potential beneficial effects of nicotine replacement therapy on COVID-19 outcomes in current smokers and outsized benefits of SARS-CoV-2 vaccination in current and former smokers. Such findings may influence clinical practice and prevention efforts and motivate additional research that explores mechanisms for these effects.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Center for Tobacco Research and Intervention, School of Medicine and Public Health, University of Wisconsin-Madison, Madison, WI, USA.
- Department of Medicine, School of Medicine and Public Health, University of Wisconsin-Madison, Madison, WI, USA.
- Department of Family Medicine and Community Health, School of Medicine and Public Health, University of Wisconsin-Madison, Madison, WI, USA.
- Department of Educational Psychology, University of Wisconsin-Madison, Madison, WI, USA.
- Department of Emergency Medicine, Geisel School of Medicine at Dartmouth, Lebanon, NH, USA.
- Institute for Clinical and Translational Research, School of Medicine and Public Health, University of Wisconsin-Madison, Madison, WI, USA.
ORCID-Profile: Thomas M Piasecki, Sean Kent, Hanna Kim, Niharika Khanna, Elizabeth Klass, Robin J Mermelstein, Elisa Tong, Janice Y Tsoh
Förderung
- NCI NIH HHS
- NCATS NIH HHS
- National Cancer Institute
Zitieren
APA
Piasecki, T. M., Smith, S. S., Baker, T. B., Slutske, W. S., Adsit, R. T., Bolt, D. M., Conner, K. L., Bernstein, S. L., Eng, O. D., Lazuk, D., Gonzalez, A., Jorenby, D. E., D'Angelo, H., Kirsch, J. A., Williams, B. S., Nolan, M. B., Hayes-Birchler, T., Kent, S., Kim, H., …, & Fiore, M. C. (2023). Smoking Status, Nicotine Medication, Vaccination, and COVID-19 Hospital Outcomes: Findings from the COVID EHR Cohort at the University of Wisconsin (CEC-UW) Study. Nicotine and Tobacco Research. https://doi.org/10.1093/ntr/ntac201
Vancouver
Piasecki TM, Smith SS, Baker TB, Slutske WS, Adsit RT, Bolt DM, et al. Smoking Status, Nicotine Medication, Vaccination, and COVID-19 Hospital Outcomes: Findings from the COVID EHR Cohort at the University of Wisconsin (CEC-UW) Study. Nicotine and Tobacco Research. 2023. doi:10.1093/ntr/ntac201
BibTeX
@article{Piasecki2023,
author = {Piasecki, Thomas M and Smith, Stevens S and Baker, Timothy B and Slutske, Wendy S and Adsit, Robert T and Bolt, Daniel M and Conner, Karen L and Bernstein, Steven L and Eng, Oliver D and Lazuk, David and Gonzalez, Alec and Jorenby, Douglas E and D'Angelo, Heather and Kirsch, Julie A and Williams, Brian S and Nolan, Margaret B and Hayes-Birchler, Todd and Kent, Sean and Kim, Hanna and Lubanski, Stan and Yu, Menggang and Suk, Youmi and Cai, Yuxin and Kashyap, Nitu and Mathew, Jomol P and McMahan, Gabriel and Rolland, Betsy and Tindle, Hilary A and Warren, Graham W and An, Lawrence C and Boyd, Andrew D and Brunzell, Darlene H and Carrillo, Victor and Chen, Li-Shiun and Davis, James M and Deshmukh, Vikrant G and Dilip, Deepika and Ellerbeck, Edward F and Goldstein, Adam O and Iturrate, Eduardo and Jose, Thulasee and Khanna, Niharika and King, Andrea and Klass, Elizabeth and Mermelstein, Robin J and Tong, Elisa and Tsoh, Janice Y and Wilson, Karen M and Theobald, Wendy E and Fiore, Michael C},
title = {Smoking Status, Nicotine Medication, Vaccination, and COVID-19 Hospital Outcomes: Findings from the COVID EHR Cohort at the University of Wisconsin (CEC-UW) Study},
journal = {Nicotine and Tobacco Research},
year = {2023},
doi = {10.1093/ntr/ntac201}
}
EUVIMED